Physicians' Academy for Cardiovascular Education

Statin-loaded HDL nanoparticles

10' education - Jan. 23, 2014 - Raphaël Duivenvoorden - Raphaël Duivenvoorden

 

 

Raphaël Duivenvoorden, MD, internist, AMC Amsterdam
Recorded: Tergooiziekenhuizen, Hilversum, The Netherlands, January 9, 2014
 

In Nature Communications January 2014 Raphaël Duivenvoorden describes an innovative nanotechnique to reduce the risk of a recurrent myocard infarct, in which inflammation is a key factor. A statin-loaded HDL-nanoparticle which by nature attaches itself to a plaque, appeares to be able to reduce inflammation in an animal model.

 Literature • 23-1-2014 • Duivenvoorden et al., Nat Commun. 2014

Statin-loaded HDL nanoparticles have local anti-inflammatory effects on plaques

HDL nanoparticles can deliver statin to atherosclerotic plaques in mice, and reduce inflammation and total plaque area.

E-Learning • Raphaël Duivenvoorden

Statin-loaded HDL nanoparticle

In Nature Communications  January 2014 Raphaël Duivenvoorden describes an innovative nanotechnique to reduce the risk of a recurrent myocard infarct, in which inflammation is a key factor. A statin-loaded HDL-nanoparticle which by nature attaches itself to a plaque, appeares to be able to reduce inflammation in an animal model.
 

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: